Further Information
V-type proton ATPase catalytic subunit A, V-ATPase subunit A, V-ATPase 69 kDa subunit, Vacuolar ATPase isoform VA68, Vacuolar proton pump subunit alpha, ATP6V1A, ATP6A1, ATP6V1A1, VPP2
For WB starting dilution is: 1:1000
For IHC-P starting dilution is: 1:50~100
This gene encodes a component of vacuolar ATPase (V-ATPase), a multisubunit enzyme that mediates acidification of eukaryotic intracellular organelles. V-ATPase dependent organelle acidification is necessary for such intracellular processes as protein sorting, zymogen activation, receptor-mediated endocytosis, and synaptic vesicle proton gradient generation. V-ATPase is composed of a cytosolic V1 domain and a transmembrane V0 domain. The V1 domain consists of three A and three B subunits, two G subunits plus the C, D, E, F, and H subunits. The V1 domain contains the ATP catalytic site. The V0 domain consists of five different subunits: a, c, c', c', and d. Additional isoforms of many of the V1 and V0 subunit proteins are encoded by multiple genes or alternatively spliced transcript variants. This encoded protein is one of two V1 domain A subunit isoforms and is found in all tissues.
- Martins-de-Souza, D., et al.Psychiatr Res 43(11):978-986(2009)
- Martins-de-Souza, D., et al. BMC Psychiatry 9, 17 (2009)
- Lu, M., et al. J. Biol. Chem. 282(34):24495-24503(2007)
- Ahmed, M., et al. J. Proteome Res. 4(3):931-940(2005)
Supplied in PBS with 0.09% (W/V) sodium azide.
batch dependent
Unconjugated
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Predicted species reactivity based on immunogen sequence: Bovine, Mouse, Pig
This ATP6V1A antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 441-468 amino acids from the Central region of human ATP6V1A.
523
V-type proton ATPase catalytic subunit A
ATP6V1A
Homo sapiens
Liquid
PREDICTED MOLECULAR WEIGHT:
68 kDa
P38606
22096378
This antibody is purified through a protein A column, followed by peptide affinity purification.
Obesity,Signal Transduction
P38606
Optimal dilutions for each application to be determined by the researcher.